Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.
复制标题
DOI:
10.3389/fncel.2015.00055
复制
发表时间:
2015
影响因子:
5.3
通讯作者:
Doering LC
中科院分区:
文献类型:
--
作者:
Wang H;Pati S;Pozzo-Miller L;Doering LC
Autism spectrum disorders (ASDs) are genetically and clinically heterogeneous and lack effective medications to treat their core symptoms. Studies of syndromic ASDs caused by single gene mutations have provided insights into the pathophysiology of autism. Fragile X and Rett syndromes belong to the syndromic ASDs in which preclinical studies have identified rational targets for drug therapies focused on correcting underlying neural dysfunction. These preclinical discoveries are increasingly translating into exciting human clinical trials. Since there are significant molecular and neurobiological overlaps among ASDs, targeted treatments developed for fragile X and Rett syndromes may be helpful for autism of different etiologies. Here, we review the targeted pharmacological treatment of fragile X and Rett syndromes and discuss related issues in both preclinical studies and clinical trials of potential therapies for the diseases.
登录
查看更多内容
DOI:
10.1124/jpet.108.143990
发表时间:
2008-12
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Zupan B;Toth M
通讯作者:
Toth M
影响因子:
17.1
作者:
Berry-Kravis, Elizabeth M.;Hessl, David;Hagerman, Randi J.
通讯作者:
Hagerman, Randi J.
DOI:
10.1089/cap.2006.16.525
发表时间:
2006-10-01
影响因子:
1.9
作者:
Berry-Kravis, Elizabeth;Krause, Sue Ellen;Hagerman, Randi
通讯作者:
Hagerman, Randi
影响因子:
5.3
作者:
Abekhoukh S;Bardoni B
通讯作者:
Bardoni B
DOI:
10.1097/dbp.0b013e31817dc447
发表时间:
2008-08-01
影响因子:
2.4
作者:
Berry-Kravis, Elizabeth;Sumis, Allison;Greenough, William T.
通讯作者:
Greenough, William T.